DB18401Experimental
KP1237 is a antibody-redirecting molecule composed of two binding sites (a CD38 binder and a universal antibody binding terminus binder) connected by a linker chain.
- Code names
- KP1237
Resolves to
Compound
Which companies are running trials of KP1237, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account